In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

What’s The Difference Between Mounjaro And Ozempic? Mounjaro and Ozempic can both help with weight loss but are specifically ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...

California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

( NewsNation) — The director of medical weight management at West Virginia University says a canceled pilot program that provided weight-loss drugs to state employees showed “incredible” results, with ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

Connecticut law requires Medicaid to cover certain weight loss drugs, but officials say it hasn't been happening due to cost ...

If you're headed into the end of 2024 with a large FSA balance, don't worry. A long list of items and health services are FSA ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.